«We found that PIM1 is indeed highly upregulated in
these more aggressive breast cancers that have high MYC expression,» Goga said, «and that patients with high PIM1 tend to do more poorly.»
Not exact matches
«Our discovery of these mutations is a first step in developing a genetics - based system for classifying endometriosis so that clinicians can sort out which forms of the disorder may need
more aggressive treatment and which may not,» says Ie - Ming Shih, M.D., Ph.D., the Richard W. TeLinde Distinguished Professor in the Department of Gynecology & Obstetrics at the Johns Hopkins University School of Medicine and co-director of the
Breast and Ovarian
Cancer Program at the Johns Hopkins Kimmel
Cancer Center.
Triple - negative tumors are
aggressive and
more likely to metastasize than other
breast cancers, and there is no effective treatment.
PARP inhibitors have shown efficacy for a small group of patients with
breast cancer with inherited mutations in BRCA genes, but have failed in the
more aggressive triple - negative disease.
Extensive studies have found that 20 % to 30 % of
breast cancers are characterized by over-expression of HER2, which makes the
cancer cells grow and divide faster, leading to a
cancer that's
more aggressive and
more likely to be resistant to the standard of care.
Women who have a genetic mutation face a higher risk of developing a second
breast cancer and may wish to consider
more aggressive treatment, preventive measures or additional screening.
Recent studies have shown an increase in women with
breast cancer choosing this
more aggressive surgery, called contralateral prophylactic mastectomy, which raises the question of potential overtreatment among these patients.
Women who pursue a
more aggressive surgery for early stage
breast cancer have nearly eight times the odds of reporting substantial employment disruptions, according to a new study from University of Michigan Comprehensive Cancer Center resear
cancer have nearly eight times the odds of reporting substantial employment disruptions, according to a new study from University of Michigan Comprehensive
Cancer Center resear
Cancer Center researchers.
The study, which will be published December 21 in the Journal of Cell Biology, suggests that the loss of these particular Numb proteins makes
breast cancers more aggressive and resistant to chemotherapy, but points the way toward new therapeutic approaches that could improve patient outcome by preserving p53 levels.
«Double mastectomy tied to
more missed work: As
more breast cancer patients are choosing to remove both
breasts, researchers examine the impact this
aggressive surgery has on their employment.»
The old idea that
cancer is less
aggressive in the elderly is not entirely without merit:
breast and prostate
cancers tend to grow
more slowly in older patients.
A new study finds that
more than half of women with early stage
breast cancer considered an
aggressive type of surgery to remove both
breasts.
Although prolonged breastfeeding reduces overall
cancer risk, women have an increased risk of developing
breast cancer for the first 5 to 10 years following pregnancy, and these
cancers tend to be
more aggressive.
Researchers at Washington University School of Medicine in St. Louis have discovered why
breast cancer patients with dense
breasts are
more likely than others to develop
aggressive tumors that spread.
It has been recognized that the
more aggressive triple - negative
breast cancer occurs
more frequently in African American women, but no previous study has examined racial differences in tumor genotype and how they might contribute to the risk of
cancer recurrence.
«In addition to having a higher prevalence of triple - negative
breast cancers than Caucasian women — something that has been documented in previous studies — we found that African American women with
breast cancer had a significantly higher prevalence of the TP53 driver mutation, basal tumor subtype and greater genomic diversity within tumors, all of which suggest more aggressive tumor biology,» says Tanya Keenan, MD, of the MGH Cancer Center, lead author of the
cancer had a significantly higher prevalence of the TP53 driver mutation, basal tumor subtype and greater genomic diversity within tumors, all of which suggest
more aggressive tumor biology,» says Tanya Keenan, MD, of the MGH
Cancer Center, lead author of the
Cancer Center, lead author of the study.
Although
breast cancer is somewhat
more aggressive in South Asian and Black women than in White women, this is largely due to age differences between ethnic groups in the UK, according to new research.
The results suggest that the pockets of stiffer extracellular matrix in the
breasts of obese women contribute to tumor growth as well as to
more aggressive cancers, Fischbach says: «People always think it's all about soluble factors, chemicals.
Compared to other types of
breast cancer, triple negative
breast cancers are often
more aggressive and have fewer treatment options.
«Triple - negative
breast cancers tend to be
more aggressive compared to other types of
breast cancers, and being able to predict response to therapy could greatly impact treatment decisions and patient outcomes,» says study author Shaveta Vinayak, MD, oncologist at UH Case Medical Center and Assistant Professor at Case Western Reserve University School of Medicine.
Like pervasive hypertension, some
cancers, such as prostate and
breast, tend to occur earlier and be
more aggressive in blacks than whites, said Dr. Edward J. Kruse, chief of surgical oncology at MCG and the Georgia
Cancer Center.
If validated in larger studies, this breakthrough could mean that it may be possible to identify those at the highest risk of their
breast cancer spreading, with
more aggressive treatments targeted specifically to them, while those at low risk could be spared treatments that may not benefit them, as well as the subsequent side - effects.
The researchers found that non-Hispanic white women were
more likely to have smaller tumors, and
more likely to have the less -
aggressive HR + / HER2 - subtype of
breast cancer, compared with African - American women, who were
more likely to have large tumors,
more likely to have the
aggressive triple - negative
breast cancer, and 40 to 70 percent
more likely to be diagnosed at stage 4 of all subtypes of
breast cancer.
The rigidity actually makes
breast cancer turn
more aggressive.
The researchers found that minority women are
more likely to have
aggressive subtypes of
breast cancer and were less likely to receive guidelines - based standard of care as compared to non-Hispanic white women.
A new score that could identify certain women with primary
breast cancer in need of
more or less
aggressive treatments could play a pivotal role in ensuring they are given the best possible chance of survival, while only giving treatments such as chemotherapy when it's necessary.
It's the
aggressive, triple - negative basal - like
breast cancer that seems to be reduced by breastfeeding
more so than is ER / PR positive
breast cancer, which is
more treatable.
These
breast cancers tend to be
more aggressive, with greater frequency of hormone receptor negativity and potential HER2 positivity.
African American women are
more often diagnosed with
aggressive, late - stage
breast cancers — resulting in mortality rates that are 44 % higher than for Caucasian women.
And a study released in March 2008 by researchers at the University of Texas M.D. Anderson
Cancer Center in Houston showed that obese and overweight women also had lower breast cancer survival rates and a greater chance of more aggressive disease than average - weight or underweight
Cancer Center in Houston showed that obese and overweight women also had lower
breast cancer survival rates and a greater chance of more aggressive disease than average - weight or underweight
cancer survival rates and a greater chance of
more aggressive disease than average - weight or underweight women.
It is also important to note that inflammatory
breast cancer is much
more aggressive than the other types of invasive
breast cancers we have discussed, including both invasive ductal carcinoma and invasive lobular carcinoma.